Assessment of Barriers toward Initiating Insulin among Gestational Diabetes Pregnant Women, Diabetes Center, Hera’a General Hospital, Makkah — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Assessment of Barriers toward Initiating Insulin among Gestational Diabetes Pregnant Women, Diabetes Center, Hera’a General Hospital, Makkah
Family Medicine Department, King Fahad Armed Forces hospital, Jeddah, Kingdom of Saudi Arabia
1 Family Medicine Department, King Fahad Armed Forces hospital, Jeddah, Kingdom of Saudi Arabia
Background: Gestational diabetes mellitus (GDM) is one of the most common pathologies in pregnancy. Unfortunately, both clinicians and patients are often reluctant to begin insulin therapy, a phenomenon that has been known as psychological insulin resistance (PIR). Objectives: To assess the barriers of initiating insulin among GDM pregnant women. Patients and Methods: An observational cross-sectional study was conducted in the GDM clinic, Diabetes Center in Hera’a General Hospital, Makkah, Saudi Arabia in a period of 4 months. A self-administered validated questionnaire was adopted. It included socio-demographic data of women, perceived (personal, social, pharmacological, occupational and misconception) barriers towards insulin therapy and possible solutions to overcome these barriers. Results: A total of 164 pregnant women with gestational diabetes were included in the study. The age of 36.4% of them exceeded 35 years. Among personal barriers, preferring other treatment methods over insulin (56.4%) and unaware of insulin dose control method (45.4%) were commonly reported. Regarding family barriers, 23.6% reported past family experience of insulin-related complications. Concerning side effects, fear of hypoglycemia (59.4%) and fear of weight gain (50.9%) were most frequently reported barriers against use of insulin. Regarding misconceptions about insulin injections, 26% believed that insulin is addictive; the injection will continue for life. Among work-related barriers, irregular eating times during working hours and long working hours (55.2%) were barriers for insulin use. Facilitating access to healthcare services (94%), engage the patient in decision-making and development of the treatment plan (91.6%), activate virtual clinics and social media for remote follow-up (86.6%) and organize social support groups for pregnant women who use insulin to share their experiences were the most frequently reported possible solutions to initiate and commit to insulin therapy. Conclusion: Various barriers were identified against initiation of insulin therapy in the management of gestational diabetes; mostly due to personal factors, misconception and work-related factors. Prompt actions are needed to overcome these barriers.
World Health Organization (1999) Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. https://apps.who.int/iris/handle/10665/66040
Cypryk, K., Szymczak, W., Czupryniak, L., Sobczak, M. and Lewiński, A. (2008) Gestational Diabetes Mellitus—An Analysis of Risk Factors. Endokrynologia Polska, 59, 393-397.
Bevier, W.C., Jovanovic-Peterson, L. and Peterson, C.M. (1995) Pancreatic Disorders of Pregnancy. Diagnosis, Management, and Outcome of Gestational Diabetes. Endocrinology and Metabolism Clinics of North America, 24, 103-138. https://doi.org/10.1016/S0889-8529(18)30055-0
Jovanovic, L. and Pettitt, D.J. (2001) Gestational Diabetes Mellitus. JAMA: The Journal of the American Medical Association, 286, 2516-2518. https://doi.org/10.1001/jama.286.20.2516
Association AAD (2004) Gestational Diabetes Mellitus. Diabetes Care, 27, s88-s90. https://doi.org/10.2337/diacare.27.2007.S88
International Diabetes Federation (2013) IDF Diabetes Atlas. 6th Edition, International Diabetes Federation, Brussels. https://www.idf.org/component/attachments/attachments.html?id=813&task=download
Garrison, A. (2015) Screening, Diagnosis, and Management of Gestational Diabetes Mellitus. American Family Physician, 91, 460-467.
Tieu, J., Middleton, P., Crowther, C.A. and Shepherd, E. (2017) Preconception Care for Diabetic Women for Improving Maternal and Infant Health. Cochrane Database of Systematic Reviews, 8, CD007776. https://doi.org/10.1002/14651858.CD007776.pub3
Lawrence, J.M. (2011) Women with Diabetes in Pregnancy: Different Perceptions and Expectations. Best Practice & Research Clinical Obstetrics & Gynaecology, 25, 15-24. https://doi.org/10.1016/j.bpobgyn.2010.10.003
Stratton, I.M., Adler, A.I., Neil, H.A., et al. (2000) Association of Glycaemia with Macrovascular and Microvascular Complications of Type 2 Diabetes (UKPDS 35): Prospective Observational Study. BMJ, 321, 405-412. https://doi.org/10.1136/bmj.321.7258.405
Woudenberg, Y.J., Lucas, C., Latour, C., et al. (2012) Acceptance of Insulin Therapy: A Long Shot? Psychological Insulin Resistance in Primary Care. Diabetic Medicine, 29, 796-802. https://doi.org/10.1111/j.1464-5491.2011.03552.x
Peyrot, M., Rubin, R.R., Lauritzen, T., et al. (2005) Resistance to Insulin Therapy among Patients and Providers: Results of the Cross-National Diabetes Attitudes, Wishes, and Needs (DAWN) Study. Diabetes Care, 28, 2673-2679. https://doi.org/10.2337/diacare.28.11.2673
Lingvay, I., Kaloyanova, P.F., Adams-Huet, B., et al. (2007) Insulin as Initial Therapy in Type 2 Diabetes: Effective, Safe, and Well Accepted. Journal of Investigative Medicine, 55, 62-68. https://doi.org/10.2310/6650.2007.06036
Ratanawongsa, N., Crosson, J.C., Schillinger, D., et al. (2012) Getting under the Skin of Clinical Inertia in Insulin Initiation: The Translating Research into Action for Diabetes (TRIAD) Insulin Starts Project. The Diabetes Educator, 38, 94-100. https://doi.org/10.1177/0145721711432649
Riddle, M.C. (2002) The Underuse of Insulin Therapy in North America. Diabetes/Metabolism Research and Reviews, 18, S42-S429. https://doi.org/10.1002/dmrr.277
Brod, M., Kongsø, J.H., Lessard, S. and Christensen, T.L. (2009) Psychological Insulin Resistance: Patient Beliefs and Implications for Diabetes Management. Quality of Life Research, 18, 23. https://doi.org/10.1007/s11136-008-9419-1
Martis, R., Brown, J., McAra-Couper, J. and Crowther, C.A. (2018) Enablers and Barriers for Women with Gestational Diabetes Mellitus to Achieve Optimal Glycaemic Control—A Qualitative Study Using the Theoretical Domains Framework. BMC Pregnancy and Childbirth, 18, 91. https://doi.org/10.1186/s12884-018-1710-8
American Diabetes Association (2018) Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes. Diabetes Care, 41, S137-S143. https://doi.org/10.2337/dc18-S013
Diabetes Canada Clinical Practice Guidelines Expert Committee (2018) Diabetes Canada: Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes, 42, S1-S325.
Hadden, D.R. (2001) When and How to Start Insulin Treatment in Gestational Diabetes: A UK Perspective. Diabetic Medicine, 18, 960-964. https://doi.org/10.1046/j.1464-5491.2001.00412.x
Mecacci, F., Carignani, L., Cioni, R., et al. (2003) Maternal Metabolic Control and Perinatal Outcome in Women with Gestational Diabetes Treated with Regular or Lispro Insulin: Comparison with Nondiabetic Pregnant Women. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 111, 19-24. https://doi.org/10.1016/S0301-2115(03)00157-X
Kalra, S., Ghosal, S. and Shah, P. (2017) Consensus on Bridges for Barriers to Insulin Therapy. The Journal of the Association of Physicians of India, 65, 23-30.
Hui, A.L., Sevenhuysen, G., Harvey, D. and Salamon, E. (2014) Barriers and Coping Strategies of Women with Gestational Diabetes to Follow Dietary Advice. Women and Birth, 27, 292-297. https://doi.org/10.1016/j.wombi.2014.07.001
Mukona, D.M., Munjanja, S.P., Zvinavashe, M. and Stray-Pederson, B. (2017) Barriers and Facilitators of Adherence to Anti-Diabetic Therapy in Pregnant Women with Diabetes: Health Care Workers’ Perspectives. Journal of Diabetes Mellitus, 7, 160. https://doi.org/10.4236/jdm.2017.73013
Mukona, D., Munjanja, S.P., Zvinavashe, M. and Stray-Pederson, B. (2017) Barriers of Adherence and Possible Solutions to Nonadherence to Antidiabetic Therapy in Women with Diabetes in Pregnancy: Patients’ Perspective. Journal of Diabetes Research, 2017, Article ID: 3578075. https://doi.org/10.1155/2017/3578075
Karter, A.J., Subramanian, U., Saha, C., et al. (2010) Barriers to Insulin Initiation: The Translating Research into Action for Diabetes Insulin Starts Project. Diabetes Care, 33, 733-735. https://doi.org/10.2337/dc09-1184
Hussein, A., Mostafa, A., Areej, A., et al. (2019) The Perceived Barriers to Insulin Therapy among Type 2 Diabetic Patients. African Health Sciences, 19, 1638-1646. https://doi.org/10.4314/ahs.v19i1.39
Almaghaslah, D., Abdelrhman, A.K., AL-Masdaf, S.K., Majrashi, L.M., et al. (2018) Factors Contributing to Non-Adherence to Insulin Therapy among Type 1 and Type 2 Diabetes Mellitus Patients in Asser Region, Saudi Arabia. Biomedical Research, 29, 2090-2095. https://doi.org/10.4066/biomedicalresearch.29-18-503
Nielsen, K.K., de Courten, M. and Kapur, A. (2012) Health System and Societal Barriers for Gestational Diabetes Mellitus (GDM) Services-Lessons from World Diabetes Foundation Supported GDM Projects. BMC International Health and Human Rights, 12, 33. https://doi.org/10.1186/1472-698X-12-33
International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger, B.E., Gabbe, S.G., Persson, B., et al. (2010) International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care, 33, 676-682. https://doi.org/10.2337/dc09-1848
Devsam, B.U., Bogossian, F.E. and Peacock, A.S. (2013) An Interpretive Review of Women’s Experiences of Gestational Diabetes Mellitus: Proposing a Framework to Enhance Midwifery Assessment. Women and Birth, 26, e69-e76. https://doi.org/10.1016/j.wombi.2012.12.003